DENTSPLY SIRONA Inc. (XRAY)

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.   NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders.

Besides Wall Street's top-and-bottom-line estimates for Dentsply (XRAY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation

As of April 1, Burkhart Dental Supply will represent Dentsply Sirona's full portfolio of dental technology solutions in addition to preventive and restorative solutions it already distributes. The expanded partnership is designed to give dental professionals more comprehensive access to the tools they rely on every day, combining digital technologies, clinical products, and local support to help practices streamline workflows and adopt new technology with confidence.

XRAY gears up for Q4 results amid U.S. weakness, tariff headwinds and a lowered outlook as investors watch for signs of stabilization.

DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report)'s stock price gapped up before the market opened on Thursday after Bank of America upgraded the stock from a neutral rating to a buy rating. The stock had previously closed at $12.49, but opened at $13.12. Bank of America now has a $17.00 price target on the

Cooper Companies (NASDAQ: COO - Get Free Report) and DENTSPLY SIRONA (NASDAQ: XRAY - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation. Profitability This table compares Cooper Companies and DENTSPLY

Dentsply (XRAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DENTSPLY SIRONA (NASDAQ: XRAY - Get Free Report) is projected to release its Q4 2025 results after the market closes on Thursday, February 26th. Analysts expect the company to announce earnings of $0.28 per share and revenue of $926.3960 million for the quarter. Individuals can find conference call details on the company's upcoming Q4 2025 earning

Cibc World Market Inc. reduced its position in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 42.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 536,540 shares of the medical instruments supplier's stock after selling 388,618 shares during the quarter.

DENTSPLY SIRONA Inc. (NASDAQ: XRAY - Get Free Report) has received an average rating of "Reduce" from the fourteen brokerages that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating on the company.

Exploring the Fourth Quarter 2025 13F Filing John Rogers (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insigh

CHARLOTTE, N.C., Feb. 05, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, February 26, 2026, at 4:30 p.m. EST to review its fourth quarter and full year 2025 financial results. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.

Mitsubishi UFJ Trust and Banking Corp increased its position in DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 1,836.7% in the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 105,938 shares of the medical instruments supplier's stock after acquiring an additional 100,468 shares during the quarter.

Cooke and Bieler LP lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) by 6.9% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,522,989 shares of the medical instruments supplier's stock after selling 631,475 shares during

Dentsply Sirona Inc. (XRAY) is the world's largest supplier of dental products and technologies, operating in over 100 countries. XRAY's business is segmented into Connected Technology Solutions, Orthodontic and Implant Solutions, Essential Dental Solutions, and the smaller Wellspect Healthcare. Despite performance issues, its investment grade bonds offering 8.5% current yield remain appealing.